NCT06571669ClinicalTrials.gov
BOOM-IBD2 Pivotal Clinical Trial
BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.
בקצרה
Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends…
התערבותידרושים 137 משתתפים19 אתריםמדינה אחת
קטגוריות
רשום במרשם אחד
- ClinicalTrials.govNCT06571669פתיחת רשומה זו ב־ClinicalTrials.govסונכרן החודש שעבר
מחקר יחיד יכול להיות רשום בכמה מרשמים. אנו מציגים אותו פעם אחת ומקשרים לכל רשומה שברשותנו.
מידע הניסוי מוצג כפי שפורסם על ידי המרשם, בשפת המקור שלו.
מתעניינים במחקר הזה?
התחברות או צרו חשבון כדי לרשום את התעניינותכם ולעקוב אחר המחקר הזה.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2024-08-26; recorded start 2025-01-31
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Not stated: Participants are not randomly assignedAllocation is recorded as non-randomised
- Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
- Not stated: Open label (no blinding)Masking is recorded as none (open label)
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Not stated: No other studies from this sponsor are in this databaseCounted from the lead sponsor named in the record (Boomerang Medical)
- Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
- The record lists 2 conditions.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation0/20
Allocation not stated in the record
- Blinding0/20
Open-label
- Control arm0/15
No comparator arm stated in the record
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre8/8
Multi-centre: 19 sites
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A small study: 137 participants (target), run at 19 sites.
How this score is built
- Enrolment20/40
137 participants (target)
- Site count15/25
19 sites
- Country count0/15
Single country
- Planned duration8/10
Planned over about 34 months
- Sponsor scale0/10
Boomerang Medical has led 1 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
תקציר
Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a nerve near the tailbone. It is placed during a same-day procedure.
מצבים רפואיים
- Ulcerative Colitis
- Inflammatory Bowel Diseases
זכאות
| מין | הכול |
|---|---|
| גילאים | 18 Years – 85 Years |
| מתנדבים בריאים | לא |
זכאות כפי שנכתבה במרשם
זכאות במשפטים פשוטים
הקריטריונים של רשומה זו טרם פורקו למשפטים נפרדים. טקסט המרשם שלמעלה שלם והוא הגרסה המחייבת.
תכנון המחקר
| סוג המחקר | התערבותי |
|---|---|
| שלב | לא רלוונטי |
| הקצאה | לא רלוונטי |
| מודל ההתערבות | SINGLE_GROUP |
| מטרה ראשית | TREATMENT |
| הסתרה | NONE (0) |
| גיוס | דרושים 137 משתתפים |
נותן חסות ושותפים
- Boomerang Medical נותן חסות
זרועות והתערבויות
- Treatment ArmEXPERIMENTAL
Patients implanted with neuromodulation
התערבויות
- התקן Neuromodulation
Neuromodulation
מדדי תוצאה
מדד תוצאה ראשוני
Bowel Urgency
Bowel urgency at 12 weeks using the urgency numeric rating scale (URNS). The Urgency NRS is a patient-reported outcome (PRO) that quantifies the severity of bowel urgency on a scale from 0 to 10, where 0 equals no bowel urgency and 10 equals worst possible urgency.
מסגרת זמן 12 weeks
תאריכים
| תאריך התחלה | 31 בינואר 2025 (בפועל) |
|---|---|
| סיום ראשוני | 28 בפברואר 2027 (משוער) |
| סיום | 30 בנובמבר 2027 (משוער) |
| פורסם לראשונה | 26 באוגוסט 2024 (בפועל) |
| עודכן לאחרונה | 6 באוגוסט 2026 |
| התוצאות פורסמו | לא צוין ברשומת המרשם |
| המצב אומת לאחרונה | אוגוסט 2026 |
בפועל פירושו שהאירוע התרחש. משוער פירושו שנותן החסות צופה אותו. שתי המשמעויות שונות זו מזו.
מיקומים
16 אתרים מגייסים
United States
| מתקן | עיר | מדינה או אזור | מצב |
|---|---|---|---|
| Amarillo Premier Research (Objective Health) | Amarillo | Texas | מגייס |
| UNC Chapel Hill | Chapel Hill | North Carolina | מגייס |
| Columbia Digestive Health Research (Objective Health) | Columbia | South Carolina | מגייס |
| Gastroenterology Medical Clinic (Objective Health) | Folsom | California | מגייס |
| GI Alliance | Jackson | Mississippi | מגייס |
| Las Vegas Medical Research LLC, DBA Vector Clinical Trials | Las Vegas | Nevada | מגייס |
| Center for Colorectal Innovation | Los Angeles | California | מגייס |
| Northwell Health North Shore University Hospital | Manhasset | New York | מגייס |
| Great Lakes Gastro | Mentor | Ohio | בוטל |
| Columbia University Irving Medical Center/New York Presbyterian Hospital | New York | New York | מגייס |
| Hoag Hospital | Newport Beach | California | מגייס |
| PAMF (Palo Alto Medical Foundation) | Palo Alto | California | מגייס |
| Pennsylvania Hospital | Philadelphia | Pennsylvania | טרם מגייס |
| Sanford Health | Sioux Falls | South Dakota | מגייס |
| Gateway GI Research (Objective Health) | St Louis | Missouri | מגייס |
| Digestive Research of Central Texas (Objective Health) | Waco | Texas | מגייס |
| Kansas Gastro | Wichita | Kansas | מגייס |
| Digestive Health Research of North Texas (Objective Health) | Wichita Falls | Texas | פעיל, ללא גיוס |
| MN Urology | Woodbury | Minnesota | מגייס |
מסמכי המחקר
לא צורפו מסמכים ברשומת מרשם זו.
שינויים לאורך זמן
לא נרשמו שינויים מאז שקלטנו רשומה זו לראשונה.
שינוי נרשם בכל פעם שנותן החסות מעדכן את רשומת המרשם. מצב, תאריכים, גיוס ואתרים מופיעים כאן ככל שהם משתנים.